|
Patients with
high blood pressure and left ventricular hypertrophy, but no signs
of vascular disease, have fewer strokes when treated with an angiotensin
II receptor-blocker drug instead of a beta-blocker, according
to a report in the August 5th issue of Annals of Internal Medicine..
The researchers
made this finding after studying 6,886 predominantly white patients
and giving them either the angiotensin II receptor-blocker drug
losartan or the beta-blocker atenolol.
During
the five-year follow-up period, the researchers monitored the patients' blood
pressure and routinely checked for complications such as heart attacks and strokes. Losartan
and atenolol were similar in their ability to lower and control blood pressure,
even though most patients in both groups needed two to three drugs. Although
the number of heart attacks in both groups were nearly the same, fewer losartan
patients had strokes and developed diabetes.
More patients
in the atenolol group (10 percent) had drug-related side effects
than patients in the losartan group (6 percent).
Other
sources: Annals of Internal Medicine 2003;139:169-177
|